butaphosphan with vitamin b12 injection and 10% + 0.005% Compound Butaphosphan 10% Vitamin B12

not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile

The cyanide concentration in blood was 3.7 mg/l

SUAD This was my first time seeking treatment outside the NHS Mandi was exceptionally knowledgeable, friendly and put me complete easy

Effect on appetite: AOD-9604 has none

But that's why I presented the question the way I did because that's the way it was presented to me